Back to JournalCo-Investments and Direct Private Deals

How to Evaluate a Private-Company Valuation

Urvashi L2 min read

Understanding the Direct Deal

Evaluating whether a private company's valuation is reasonable means comparing it against relevant reference points, since there is no public market price to anchor against, the specific comparables and methodology used matter as much as the resulting number itself.

Reading Rights, Price and Lead-Investor Quality

Useful reference points include: revenue or growth multiples of genuinely comparable listed or recently funded private companies in the same sector and stage; the trajectory of the company's own prior round valuations and whether growth in valuation has tracked growth in fundamentals; and whether the round is being priced by a credible, arm's-length lead investor or set unilaterally by the company.

Where Deal Underwriting Breaks

The common failure is anchoring only to the company's narrative about its own potential without checking it against actual comparable multiples. A compelling growth story can still be priced well above what genuinely comparable companies command, especially in periods of high investor enthusiasm for a particular sector.

Making the Investment Decision

Before committing, independently identify 3-5 genuinely comparable companies (similar sector, stage, growth rate) and their most recent valuation multiples, compare the round's implied multiple against them, and understand whether a credible arm's-length lead investor set this specific price or the company set it unilaterally.

A private-company valuation is only meaningful in comparison to genuine peers, never accept a valuation based solely on the company's own narrative about its potential.

India context: How to Evaluate a Private-Company Valuation

India context: investor reporting should be read against the fund's stated methodology, the signed documents and the date of each cash flow. Do not compare a manager's marketing number with an investor-level return without reconciling the basis. In the context of “How to Evaluate a Private-Company Valuation,” the practical issue is not whether the label sounds familiar; it is whether the documented structure and cash-flow profile fit the investor's real balance sheet.

The investor should test the decision against their own liquidity needs, concentration risk and capacity to monitor an illiquid position after committing capital.

A practical example

For example, a fund can report a strong IRR while having returned little cash. Read the number beside fund age, DPI, remaining NAV, fee treatment and the valuation basis before comparing it with another manager.

This example is not a forecast. It shows the information, liquidity and governance assumptions that need to hold for the proposed allocation to make sense.

Evidence to request before you decide

Request the underlying dated cash flows, the precise gross or net definition, fund age, NAV date, DPI, TVPI, valuation policy and treatment of subscription lines or fund-level financing. A return number without this context is not comparable.

Keep the evidence in a dated decision file and distinguish source documents from marketing material. If a material claim cannot be supported, record it as unverified rather than assuming it is either true or false.

What to do next

Put each metric on a common basis: same date, same fee treatment, same fund population and same vintage context. If those labels cannot be matched, report the comparison as unresolved rather than forcing a ranking.

What to check: no private-market metric is self-explanatory. A figure becomes comparable only when its cash-flow dates, gross or net basis, fund population, vintage and valuation date match the alternative being compared.

Key takeaways

  • Private-company valuation requires comparison against relevant reference points, there's no public price to anchor to.
  • Compare revenue or growth multiples against genuinely comparable companies in the same sector and stage.
  • A compelling growth narrative can still be priced well above what real peers actually command.
  • Check whether a credible arm's-length lead investor set the price, or the company set it unilaterally.

Related questions

What should an investor verify first?

The valuation multiples of 3-5 genuinely comparable companies in the same sector and growth stage.

Which documents matter most?

The company's prior round valuation history, to see whether growth has tracked fundamentals.

What is the main downside to test?

Anchoring to the company's own growth narrative without checking it against real comparable multiples.

How should the final decision be made?

Confirm whether a credible arm's-length lead investor set the price, or the company set it unilaterally.

Need personalized advice?

Schedule a conversation about your private market allocation goals.

Request an advisory call